Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganetespib + Docetaxel in Advanced NSCLC (GALAXY-2)
NCT01798485Phase 3Terminated
- Sponsor
- Synta Pharmaceuticals Corp.
- Start
- Apr 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of ganetespib in non-small cell lung cancer (NSCLC), sponsored by Synta Pharmaceuticals Corp.. Started Apr 2013; status: terminated.
02
Drugs
ganetespib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01798485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01798485.